We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

159 hedge funds and large institutions have $1.47B invested in Aerie Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 38 increasing their positions, 69 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 14

91% more call options, than puts

Call options by funds: $16.7M | Put options by funds: $8.73M

15% more capital invested

Capital invested by funds: $1.28B → $1.47B (+$190M)

5% more funds holding

Funds holding: 151 → 159 (+8)

45% less repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 69

50% less funds holding in top 10

Funds holding in top 10: 6 → 3 (-3)

Holders
159
Holders Change
+8
Holders Change %
+5.3%
% of All Funds
3.96%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.07%
New
31
Increased
38
Reduced
69
Closed
14
Calls
$16.7M
Puts
$8.73M
Net Calls
+$7.98M
Net Calls Change
+$4.8M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$116M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$18.4M
3
SIG
Senator Investment Group
New York
+$17.8M
4
Two Sigma Investments
Two Sigma Investments
New York
+$11.3M
5
Invesco
Invesco
Georgia
+$11M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$46.5M
2
Citadel Advisors
Citadel Advisors
Florida
-$30.7M
3
Jennison Associates
Jennison Associates
New York
-$13.1M
4
PI
Putnam Investments
Massachusetts
-$9.38M
5
ACA
Avoro Capital Advisors
New York
-$8.25M
Name Holding Trade Value Shares
Change 		Change in
Stake
CCI
26
Columbus Circle Investors
$12.8M +$2.17M +48,689 +21%
VOYA Investment Management
27
VOYA Investment Management
Georgia
$12.7M +$78.1K +1,752 +0.6%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$12M +$3.05M +68,360 +35%
Geode Capital Management
29
Geode Capital Management
Massachusetts
$11.9M +$373K +8,365 +3%
Two Sigma Investments
30
Two Sigma Investments
New York
$11.5M +$11.3M +253,190 New
Goldman Sachs
31
Goldman Sachs
New York
$10.1M +$2.21M +49,473 +29%
Citigroup
32
Citigroup
New York
$9.22M +$2.82M +63,198 +45%
RHJA
33
Rice Hall James & Associates
California
$8.99M -$25.1K -562 -0.3%
WRF
34
Waddell & Reed Financial
Kansas
$8.71M – – –
NC
35
Northpointe Capital
Michigan
$7.41M -$1.88M -42,199 -21%
Charles Schwab
36
Charles Schwab
California
$6.17M +$61.9K +1,388 +1%
TCIM
37
TIAA CREF Investment Management
New York
$5.19M -$280K -6,289 -5%
Thrivent Financial for Lutherans
38
Thrivent Financial for Lutherans
Minnesota
$4.95M – – –
ACM
39
Atika Capital Management
New York
$4.31M -$66.9K -1,500 -2%
EI
40
EAM Investors
California
$4.22M -$348K -7,796 -8%
Morgan Stanley
41
Morgan Stanley
New York
$4.2M -$1.54M -34,577 -27%
TAM
42
Tocqueville Asset Management
New York
$4.12M +$669K +15,000 +20%
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$4.04M -$275K -6,176 -6%
EIM
44
Essex Investment Management
Massachusetts
$3.98M -$1.28M -28,653 -25%
Stifel Financial
45
Stifel Financial
Missouri
$3.97M -$265K -5,950 -6%
IHM
46
Iguana Healthcare Management
New York
$3.85M -$1.34M -30,000 -26%
RPAM
47
Rhenman & Partners Asset Management
Sweden
$3.85M +$2.23M +50,000 +143%
GPCM
48
Granite Point Capital Management
Massachusetts
$3.85M -$2.21M -49,541 -37%
CS
49
Credit Suisse
Switzerland
$3.82M +$887K +19,885 +31%
RJA
50
Raymond James & Associates
Florida
$3.74M -$1.37M -30,639 -27%
1
2
3 4 5

AERI Hedge Fund Activity: Q1 2017 in Review

159 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q1 2017, worth a combined $1.47B — up 15% from $1.28B a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new AERI positions and 14 closed out — a net gain of 17 holders — while 38 added to existing stakes and 69 trimmed.

The largest buyer was BlackRock, adding an estimated $116M. The largest seller was Deerfield Management, cutting an estimated $46.5M.

  • 159 institutional investors held Aerie Pharmaceuticals (AERI) as of Q1 2017, up from 151 in Q4 2016.
  • Funds reported $1.47B of Aerie Pharmaceuticals stock for Q1 2017, up 15% quarter-over-quarter.
  • 31 funds opened new Aerie Pharmaceuticals positions in Q1 2017 and 14 closed out, a net change of +17 holders.
  • The largest Aerie Pharmaceuticals buyer in Q1 2017 was BlackRock, an estimated $116M added.
  • The largest Aerie Pharmaceuticals seller in Q1 2017 was Deerfield Management, an estimated $46.5M sold.

Based on aggregated 13F filings for Q1 2017.